Business Context and Reporting Period
Company: Jackson Acquisition Company II (JACS), a Cayman Islands exempted company and special purpose acquisition company (SPAC).
Reporting Period: Quarter ended March 31, 2025.
Business Status: The Company is a "blank check" company incorporated on September 11, 2024, with no operating revenues. It is searching for a target business in the healthcare services or technology sectors to effect a Business Combination. The Company completed its Initial Public Offering (IPO) on December 11, 2024, and has until December 11, 2026, to complete a transaction.
Key Financial Metrics
| Metric | Value (Q1 2025) | Value (Dec 31, 2024) |
|---|---|---|
| Net Income | $2,227,401 | N/A (Inception Sept 2024) |
| Operational Costs | $206,321 | N/A |
| Interest Income (Trust Account) | $2,433,722 | N/A |
| Cash (Outside Trust) | $755,968 | $949,366 |
| Investments in Trust Account | $235,292,200 | $232,858,478 |
| Total Assets | $236,280,906 | $234,005,881 |
| Working Capital | $522,736 | N/A |
| Current Liabilities | $405,164 | $357,540 |
| Promissory Note (Related Party) | $198,024 | $198,024 |
Per Share Data: Basic and diluted net income per share was $0.08 for both redeemable Class A shares and non-redeemable Class A/B shares.
Material Changes vs. Prior Period
- Trust Account Growth: Investments held in the Trust Account increased by approximately $2.43 million, driven entirely by interest earned on marketable securities (U.S. Treasury obligations and money market funds).
- Redemption Value Accretion: The redemption value of Class A ordinary shares subject to possible redemption increased from $10.12 per share to $10.23 per share, resulting in a $2,433,722 accretion charge against additional paid-in capital and retained earnings.
- Cash Position: Cash held outside the Trust Account decreased by $193,398 due to net cash used in operating activities, primarily covering formation and operational costs.
- Liabilities: Current liabilities increased by $47,624, largely due to an increase in amounts due to the Sponsor for administrative services ($30,000 incurred in Q1).
Outlook, Risks, and Management Commentary
Outlook and Liquidity: Management believes the Company has sufficient funds to sustain operations for at least one year from the filing date. The Company intends to use funds outside the Trust Account for due diligence and transaction costs. If a Business Combination is not completed by December 11, 2026, the Company will liquidate and redeem public shares.
Related Party Transactions:
- Administrative Services: The Company pays the Sponsor $10,000 per month for office space and administrative support. $30,000 was incurred in Q1 2025.
- Promissory Note: A $198,024 non-interest-bearing note to the Sponsor remains outstanding. It was amended in May 2025 to be payable upon consummation of a Business Combination or liquidation.
- Marketing Fee: A contingent fee of up to $9,200,000 (4.0% of gross IPO proceeds) is payable to Roth Capital Partners upon completion of a Business Combination.
Risks and Contingencies:
- Geopolitical Instability: The filing highlights risks associated with the Russia-Ukraine conflict and the Israel-Hamas conflict, which could disrupt capital markets and affect the search for a target.
- Going Concern: While currently sufficient, the Company may need additional financing if costs exceed estimates or if a significant number of shares are redeemed upon a Business Combination.
- Trust Account Claims: Funds in the Trust Account could be subject to claims by creditors, though the Sponsor has agreed to indemnify the Trust Account against certain third-party claims.
Investor Verification Checklist
- Trust Account Yield: Verify the current interest rate environment and its impact on the redemption value per share ($10.23 as of March 31, 2025).
- Extension Options: Confirm if the Company has the ability to extend the 24-month deadline to complete a Business Combination beyond December 11, 2026, and the associated shareholder vote requirements.
- Related Party Exposure: Review the terms of the Promissory Note and the potential conversion of Working Capital Loans into post-combination equity.
- Redemption Rights: Understand the mechanics of the 15% redemption limit for "groups" of shareholders and the impact of potential redemptions on the Company's ability to close a deal.
- Target Sector Focus: Assess the Company's progress in identifying a target within the healthcare services or technology sectors.